Dyadic adds three more to strengthen Scientific Advisory Board
14 Oct '05
3 min read
Carlos Barbas, Ph.D.
Dr. Barbas is a Professor of The Scripps Research Institute, Departments of Molecular Biology and Chemistry and The Skaggs Institute for Chemical Biology. He holds the Janet and W. Keith Kellogg II endowed Chair in Molecular Biology and Chemistry. Dr. Barbas has received honours including the Investigator Award from the Cancer Research Institute, The Scholar Award of the American Foundation for AIDS Research, and the Presidential Green Chemistry Challenge Award.
Joseph Villafranca, Ph.D.
Dr. Villafranca has served as Executive Vice President, Pharmaceutical Development and Operations at Neose Technologies, Inc., since February 2004. He joined Neose in October 2002 as Senior Vice President, Pharmaceutical Development and Operations. From 1992 to 2002 he held various positions at Bristol-Myers Squibb, serving most recently as Vice President of Biologics Strategy and Biopharmaceuticals Operations.
Dyadic International Inc is engaged in the development, manufacture and sale of biological products (proteins, enzymes, peptides and other bio-molecules), as well as the licensing of its enabling proprietary technology to business collaborators for the discovery, development and manufacture of biological products from genes.
Dyadic markets its products and services for applications in the textile, chemical, agricultural, pulp & paper, pharmaceutical, biotechnology and other industries, using its proprietary C1 Host Technology and C1 Expression and Screening Systems for the discovery, development and production of biological products.
marketing@alchempro.com
